pathologic mechanisms in Alzheimer's disease

From Aaushi
Jump to navigation Jump to search
[1]

More general terms

References

  1. ↑ Delacourte A. The natural and molecular history of Alzheimer's disease. J Alzheimers Dis. 2006;9(3 Suppl):187-94. PMID: https://www.ncbi.nlm.nih.gov/pubmed/16914858
    Mosconi L, Sorbi S, de Leon MJ, Li Y, Nacmias B, Myoung PS, Tsui W, Ginestroni A, Bessi V, Fayyazz M, Caffarra P, Pupi A. Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer's disease. J Nucl Med. 2006 Nov;47(11):1778-86. PMID: https://www.ncbi.nlm.nih.gov/pubmed/17079810
    Braak H, Rub U, Schultz C, Del Tredici K. Vulnerability of cortical neurons to Alzheimer's and Parkinson's diseases. J Alzheimers Dis. 2006;9(3 Suppl):35-44. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/16914843
    Stoub TR, deToledo-Morrell L, Stebbins GT, Leurgans S, Bennett DA, Shah RC. Hippocampal disconnection contributes to memory dysfunction in individuals at risk for Alzheimer's disease. Proc Natl Acad Sci U S A. 2006 Jun 27;103(26):10041-5. Epub 2006 Jun 19. PMID: https://www.ncbi.nlm.nih.gov/pubmed/16785436
    Bouras C, Kovari E, Herrmann FR, Rivara CB, Bailey TL, von Gunten A, Hof PR, Giannakopoulos P. Stereologic analysis of microvascular morphology in the elderly: Alzheimer disease pathology and cognitive status. J Neuropathol Exp Neurol. 2006 Mar;65(3):235-44. PMID: https://www.ncbi.nlm.nih.gov/pubmed/16651885
    Lazarov O, Peterson LD, Peterson DA, Sisodia SS. Expression of a familial Alzheimer's disease-linked presenilin-1 variant enhances perforant pathway lesion- induced neuronal loss in the entorhinal cortex. J Neurosci. 2006 Jan 11;26(2):429-34. PMID: https://www.ncbi.nlm.nih.gov/pubmed/16407539
    Small SA, Kent K, Pierce A, Leung C, Kang MS, Okada H, Honig L, Vonsattel JP, Kim TW. Model-guided microarray implicates the retromer complex in Alzheimer's disease. Ann Neurol. 2005 Dec;58(6):909-19. PMID: https://www.ncbi.nlm.nih.gov/pubmed/16315276
    Ferrer I, Barrachina M, Puig B, Martinez de Lagran M, Marti E, Avila J, Dierssen M. Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, Pick disease, and related transgenic models. Neurobiol Dis. 2005 Nov;20(2):392-400. PMID: https://www.ncbi.nlm.nih.gov/pubmed/16242644
    Luna-Munoz J, Garcia-Sierra F, Falcon V, Menendez I, Chavez-Macias L, Mena R. Regional conformational change involving phosphorylation of tau protein at the Thr231, precedes the structural change detected by Alz-50 antibody in Alzheimer's disease. J Alzheimers Dis. 2005 Sep;8(1):29-41. PMID: https://www.ncbi.nlm.nih.gov/pubmed/16155347
    Teaktong T, Graham AJ, Court JA, Perry RH, Jaros E, Johnson M, Hall R, Perry EK. Nicotinic acetylcholine receptor immunohistochemistry in Alzheimer's disease and dementia with Lewy bodies: differential neuronal and astroglial pathology. J Neurol Sci. 2004 Oct 15;225(1-2):39-49. PMID: https://www.ncbi.nlm.nih.gov/pubmed/15465084
    Duyckaerts C. Looking for the link between plaques and tangles. Neurobiol Aging. 2004 Jul;25(6):735-9; discussion 743-6. Review. No abstract available. PMID: https://www.ncbi.nlm.nih.gov/pubmed/15165696
    Nagele RG, D'Andrea MR, Lee H, Venkataraman V, Wang HY. Astrocytes accumulate A beta 42 and give rise to astrocytic amyloid plaques in Alzheimer disease brains. Brain Res. 2003 May 9;971(2):197-209. PMID: https://www.ncbi.nlm.nih.gov/pubmed/12706236
    Yang Y, Mufson EJ, Herrup K. Neuronal cell death is preceded by cell cycle events at all stages of Alzheimer's disease. J Neurosci. 2003 Apr 1;23(7):2557-63. PMID: https://www.ncbi.nlm.nih.gov/pubmed/12684440
    Kobayashi K, Nakano H, Hayashi M, Shimazaki M, Fukutani Y, Sasaki K, Sugimori K, Koshino Y. Association of phosphorylation site of tau protein with neuronal apoptosis in Alzheimer's disease. J Neurol Sci. 2003 Apr 15;208(1-2):17-24. PMID: https://www.ncbi.nlm.nih.gov/pubmed/12639720
    Christen-Zaech S, Kraftsik R, Pillevuit O, Kiraly M, Martins R, Khalili K, Miklossy J. Early olfactory involvement in Alzheimer's disease. Can J Neurol Sci. 2003 Feb;30(1):20-5. PMID: https://www.ncbi.nlm.nih.gov/pubmed/12619779
    Teaktong T, Graham A, Court J, Perry R, Jaros E, Johnson M, Hall R, Perry E. Alzheimer's disease is associated with a selective increase in alpha7 nicotinic acetylcholine receptor immunoreactivity in astrocytes. Glia. 2003 Jan 15;41(2):207-11. PMID: https://www.ncbi.nlm.nih.gov/pubmed/12509811
    Rohn TT, Rissman RA, Davis MC, Kim YE, Cotman CW, Head E. Caspase-9 activation and caspase cleavage of tau in the Alzheimer's disease brain. Neurobiol Dis. 2002 Nov;11(2):341-54. PMID: https://www.ncbi.nlm.nih.gov/pubmed/12505426
    D'Andrea MR, Nagele RG, Wang HY, Lee DH. Consistent immunohistochemical detection of intracellular beta-amyloid42 in pyramidal neurons of Alzheimer's disease entorhinal cortex. Neurosci Lett. 2002 Nov 29;333(3):163-6. PMID: https://www.ncbi.nlm.nih.gov/pubmed/12429373
    Holzer M, Gartner U, Stobe A, Hartig W, Gruschka H, Bruckner MK, Arendt T. Inverse association of Pin1 and tau accumulation in Alzheimer's disease hippocampus. Acta Neuropathol (Berl). 2002 Nov;104(5):471-81. Epub 2002 Jul 3. PMID: https://www.ncbi.nlm.nih.gov/pubmed/12410395
    Pei JJ, Braak H, Gong CX, Grundke-Iqbal I, Iqbal K, Winblad B, Cowburn RF. Up-regulation of cell division cycle (cdc) 2 kinase in neurons with early stage Alzheimer's disease neurofibrillary degeneration. Acta Neuropathol (Berl). 2002 Oct;104(4):369-76. Epub 2002 May 25. PMID: https://www.ncbi.nlm.nih.gov/pubmed/12200623
    van de Nes JA, Sandmann-Keil D, Braak H. Interstitial cells subjacent to the entorhinal region expressing somatostatin-28 immunoreactivity are susceptible to development of Alzheimer's disease-related cytoskeletal changes. Acta Neuropathol (Berl). 2002 Oct;104(4):351-6. Epub 2002 May 22. PMID: https://www.ncbi.nlm.nih.gov/pubmed/12200620
    Nagele RG, D'Andrea MR, Anderson WJ, Wang HY. Intracellular accumulation of beta-amyloid(1-42) in neurons is facilitated by the alpha 7 nicotinic acetylcholine receptor in Alzheimer's disease. Neuroscience. 2002;110(2):199-211. PMID: https://www.ncbi.nlm.nih.gov/pubmed/11958863
    Kovacs T, Cairns NJ, Lantos PL. Olfactory centres in Alzheimer's disease: olfactory bulb is involved in early Braak's stages. Neuroreport. 2001 Feb 12;12(2):285-8. PMID: https://www.ncbi.nlm.nih.gov/pubmed/11209936
    Nadel L. The parahippocampal region: basic science and clinical implications. Hippocampus. 2000;10(2):133-5. No abstract available. PMID: https://www.ncbi.nlm.nih.gov/pubmed/10791834
    Thal DR, Holzer M, Rub U, Waldmann G, Gunzel S, Zedlick D, Schober R. Alzheimer-related tau-pathology in the perforant path target zone and in the hippocampal stratum oriens and radiatum correlates with onset and degree of dementia. Exp Neurol. 2000 May;163(1):98-110. PMID: https://www.ncbi.nlm.nih.gov/pubmed/10785448
    Perry E, Martin-Ruiz C, Lee M, Griffiths M, Johnson M, Piggott M, Haroutunian V, Buxbaum JD, Nasland J, Davis K, Gotti C, Clementi F, Tzartos S, Cohen O, Soreq H, Jaros E, Perry R, Ballard C, McKeith I, Court J. Nicotinic receptor subtypes in human brain ageing, Alzheimer and Lewy body diseases. Eur J Pharmacol. 2000 Mar 30;393(1-3):215-22. PMID: https://www.ncbi.nlm.nih.gov/pubmed/10771016
    Pei JJ, Braak E, Braak H, Grundke-Iqbal I, Iqbal K, Winblad B, Cowburn RF. Distribution of active glycogen synthase kinase 3beta (GSK-3beta) in brains staged for Alzheimer disease neurofibrillary changes. J Neuropathol Exp Neurol. 1999 Sep;58(9):1010-9. PMID: https://www.ncbi.nlm.nih.gov/pubmed/10499443
    Botez G, Probst A, Ipsen S, Tolnay M. Astrocytes expressing hyperphosphorylated tau protein without glial fibrillary tangles in argyrophilic grain disease. Acta Neuropathol (Berl). 1999 Sep;98(3):251-6. PMID: https://www.ncbi.nlm.nih.gov/pubmed/10483782

Database

Retrieved from "https://aaushi.info/w/index.php?title=A15389&oldid=969933"